Brought to you by 
Inverness signs definitive agreement to buy Epocal
07 Oct 2020
Executive Summary
Inverness Medical Innovations has signed a definitive agreement to buy point-of-care testing firm and new partner Epocal. The deal was announced in the same breath as an alliance between the two for the marketing of Epocal's epoc blood gas analyzer.
Deal Industry
- In Vitro Diagnostics
- Medical Devices
-
In Vitro Diagnostics
- Biosensors
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Inverness signs definitive agreement to buy Epocal
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice